The global aneurysm clips market is forecast to reach USD 1.74 Billion by 2027, according to a new report by Reports and Data. The procedure of accessing blood vessels directly by performing a craniotomy and positioning an aneurysm clip to cut off blood supply is known as aneurysm clipping.
This procedure has been used for years to treat brain aneurysms and is not only effective and safe but can be performed on all types of aneurysm. It lowers the risk of recurrence in many patients. Rising demand for surgical procedures and integration of highly compatible materials into the clips are expected to influence the growth of the market. Moreover, the availability of biocompatible aneurysm clips in a variety of shapes and sizes for applications in the neurological field is expected to create potential growth prospects of the aneurysm clips market. Further, the adoption of these clips is anticipated to accelerate by increasing access to healthcare facilities globally majorly.
In 2016, Neos Surgery developed plastic clips, which allows post-surgical checkups via Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) scans, which is not possible with a metal clip. The technology was developed through the European Union’s Eureka Eurostars program, which funded R&D with USD 1.23 million.
Top Companies Profiled in the Report Include:
Braun Melsungen AG, Peter LAZIC GmbH, KLS Martin Group, Adeor Medical AG, Rebstock Instruments GmbH, Mizuho America, Stryker Corporation, RauMedic, InoMed, and Codman & Shurtleff, among others.
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
